CSI Market
Sign In | Register

Axim Biotechnologies Inc (AXIM) Annual Balance Sheets

Annual · GAAP · USD millions
Access AXIM quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Axim Biotechnologies Inc balances growth, leverage, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
(Dec 31 2022) (Dec 31 2021) (Dec 31 2020) (Dec 31 2019)
Assets
Cash & cash equivalent0.00
Security Deposit0.01
Marketable Securities, Total MA0.00
Cash & Short-term Investments0.00
Accounts receivable0.00
Notes Receivable, Related Parties0.00
Notes, Loans and Financing Receivable, Net, Current AC0.00
Inventories0.00
Other Current Assets0.15
Prepaid Supplies PR0.00
Total Current Assets0.16
Equipment/Property/Plant Net0.13
Goodwill net0.00
Intangible Assets3.59
Prepaid Expense AS0.00
Other Assets, Noncurrent0.24
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents0.16
Operating Lease Right Of Use Asset-
Operating Lease Right Of Use Asset-
Operating Lease Right Of Use Asset0.23
Total Assets4.12
Liabilities
Accounts Payable and Accrued Liabilities, Current LI2.78
Accounts Payable and Other Accrued Liabilities0.00
Derivative Liability, Current DE2.48
Long-term Debt and Capital Lease Obligations, Current DE0.09
Other Liabilities, Current0.00
Deferred Revenue, Current DE0.30
Total Current Liabilities5.98
Long-term debt0.00
Capital Lease Obligations, Noncurrent LO0.14
Convertible Debt, Noncurrent LO1.41
Total Long-term Debt1.55
Other liabilities, Noncurrent4.25
Due To Related Party Current0.02
Advances From Shareholders Current0.30
Lease Liability Obligation-
Lease Liability Obligations-
Advances From Shareholder-
Deferred Tax Liability Intra Entity Transfer Asset Other Than Inventory-
Convertible Note Payable Including Accrued Interest Net Of Unamortized Debt Discount-
Total Liabilities11.78
Stockholders' Equity
Common Stock To Be Issued-
Common Stock Value0.02
Common Stock, Held by Subsidiary etc.-0.02
Additional Paid In Capital Common Stock64.53
Retained Earnings / Accumulated Deficit-72.18
Other Equity0.00
Common Stockholder's Equity-7.66
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-7.66
Liabilities & Stockholder's Equity4.12
4 historic quarters locked

Sign in to unlock the full Axim Biotechnologies Inc balance sheet history.

Sign In Create Free Account

About Axim Biotechnologies Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20231231)
  • Filed with the SEC: April 16, 2024
  • Source: axim_10k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001096906-24-000864

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.